DaVita Inc. (DVA)

59.05
0.09 0.15
NYSE : Health Services
Prev Close 59.14
Open 59.40
Day Low/High 58.90 / 59.45
52 Wk Low/High 48.25 / 79.11
Volume 1.00M
Avg Volume 1.55M
Exchange NYSE
Shares Outstanding 165.98M
Market Cap 9.83B
EPS 0.90
P/E Ratio 16.79
Div & Yield N.A. (N.A)

DVA LOSS NOTICE: Rosen Law Firm Reminds DaVita Inc. Investors Of Important Deadline In Class Action

Rosen Law Firm, a global investor rights law firm, reminds purchasers of DaVita Inc.

Kessler Topaz Meltzer & Check, LLP Announces Shareholder Lawsuit Filed Against DaVita Inc.

The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against DaVita Inc.

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In DaVita Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Colorado on behalf of...

Option Sellers Hold the Best Cards

Option Sellers Hold the Best Cards

They can close out early if the trade isn't going their way.

Connecting the Market Dots

How the utilities, bonds, the yen and gold are interrelated, and will the market notice?

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against DaVita Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against DaVita Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against DaVita Inc. - DVA

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of DaVita Inc.

SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of DaVita Inc., And Encourages Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against DaVita Inc.

The New #150 Most Shorted S&P 500 Component: DaVita

The New #150 Most Shorted S&P 500 Component: DaVita

The most recent short interest data has been released for the 12/30/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of DaVita Inc. And Advises Investors With Losses To Contact The Firm

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of DaVita Inc. And Advises Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating DaVita Inc.

Things May Change, but S&P Doesn't

Russell index outperforms amid improved breadth.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against DaVita Inc. - DVA

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against DaVita Inc. - DVA

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of DaVita Inc.

5 Stocks to Buy in the New Year

5 Stocks to Buy in the New Year

'Rocket Stocks' is our list of companies with short-term gain catalysts and longer-term growth potential.

Buy These 5 Rocket Stocks for New Year's Gains

Buy These 5 Rocket Stocks for New Year's Gains

These stocks are showing off short-term gain catalysts and longer-term growth potential.

DaVita May See Greater Gains Once the Negative Sentiment Subsides

DaVita May See Greater Gains Once the Negative Sentiment Subsides

This kidney care provider hasn't lived up to high expectations, but the stock could be a value play in an overbought market.

What's the Big Deal About the Banks?

But the bonds are what I noticed.

Humana To Add JSA Medical Group's New Primary Care Practices Designed Exclusively For Medicare Beneficiaries To Florida Medicare Advantage Plan Networks

Humana To Add JSA Medical Group's New Primary Care Practices Designed Exclusively For Medicare Beneficiaries To Florida Medicare Advantage Plan Networks

To offer patient-centered care for Medicare beneficiaries, JSA Medical Group, a DaVita Medical Group (NYSE: DVA), and Humana Inc.

What Makes for a Truly Great Stock?

What Makes for a Truly Great Stock?

This century's best-performing names offer some clues.

DaVita (DVA) Stock Advances on Medicaid Policy Change

DaVita (DVA) Stock Advances on Medicaid Policy Change

DaVita (DVA) today announced it will suspend support for applications to the American Kidney Fund by Medicaid patients who are seeking additional coverage under the Affordable Care Act.

DaVita Becomes #239 Most Shorted S&P 500 Component, Replacing Public Service Enterprise Group

DaVita Becomes #239 Most Shorted S&P 500 Component, Replacing Public Service Enterprise Group

The most recent short interest data has been released for the 10/14/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

5 Big Stocks to Buy for October Gains

5 Big Stocks to Buy for October Gains

These stocks have both short-term gain catalysts and longer-term growth potential.

DaVita (DVA) Stock Downgraded to 'Neutral' at BofA/Merrill

DaVita (DVA) Stock Downgraded to 'Neutral' at BofA/Merrill

DaVita's (DVA) stock rating was reduced to 'neutral' from 'buy' at BofA/Merrill on Tuesday.

Analysts' Actions -- Biogen, Gilead, CBS, VF Corp. and More

Analysts' Actions -- Biogen, Gilead, CBS, VF Corp. and More

Here are Tuesday's top research calls, including an upgrade for Gilead Sciences, downgrades for Biogen and VF Corp., and new coverage for CBS.

DaVita's Ill Health Could Be Good for Investors

DaVita's Ill Health Could Be Good for Investors

Bad news weighs on health care company's stock, which offers an opportunity.

DaVita (DVA) Stock Slides as CMS Investigates Inappropriate Patient Steering

DaVita (DVA) Stock Slides as CMS Investigates Inappropriate Patient Steering

The Centers for Medicare and Medicaid Services issued a request for information seeking comment from DaVita (DVA) on concerns of patient steering.

Tracking Bullish and Bearish Reversals

Tracking Bullish and Bearish Reversals

These stocks have made U-turns in the past week.

Bearish Bets: A Health-Care Firm, an Engineering Giant and Other Stocks That Look Good Short

DVA, STN, IRM, WEYS and OFIX were all recently downgraded by TheStreet's Quant Ratings.

DaVita HealthCare's Chart Is Doing Poorly

DaVita HealthCare's Chart Is Doing Poorly

A 50% retracement to around the $68 area on DVA seems likely.

Trade-Ideas: DaVita HealthCare Partners (DVA) Is Today's "Roof Leaker" Stock

Trade-Ideas: DaVita HealthCare Partners (DVA) Is Today's "Roof Leaker" Stock

Trade-Ideas LLC identified DaVita HealthCare Partners (DVA) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate

TheStreet Quant Rating: C (Hold)